Ginkgo Bioworks Holdings (DNA) Total Current Liabilities (2020 - 2026)

Ginkgo Bioworks Holdings has reported Total Current Liabilities for 7 years, with the latest figure at $79.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 31.19% year-over-year to $79.6 million; the trailing twelve-month figure through Mar 2026 stood at $79.6 million (down 31.19% YoY), and the FY2025 full-year result was $96.0 million, down 10.53% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $79.6 million, down from $96.0 million in the prior quarter.
• The five-year high for Total Current Liabilities was $191.7 million in Q1 2023, with the low at $79.6 million in Q1 2026.
• Historically, Total Current Liabilities has averaged $137.6 million across 5 years, with a median of $135.0 million in 2022.
• Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 11100.25% — and 2025, when it tumbled 41.79%.
• Ginkgo Bioworks Holdings' Total Current Liabilities stood at $173.0 million in 2022, then decreased by 5.26% to $163.9 million in 2023, then tumbled by 34.54% to $107.3 million in 2024, then retreated by 10.53% to $96.0 million in 2025, then fell by 17.06% to $79.6 million in 2026.
• The last three Total Current Liabilities figures came in at $79.6 million (Q1 2026), $96.0 million (Q4 2025), and $115.3 million (Q3 2025), per Business Quant data.